TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Biosorbe AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
181
|
749
|
41 |
| Financial expenses |
851
|
420
|
379 |
| Earnings before taxes |
-15,229
|
-10,205
|
-9,014 |
| EBITDA |
-11,562
|
-7,667
|
-6,299 |
| Total assets |
24,650
|
11,864
|
14,753 |
| Current assets |
3,547
|
1,837
|
3,156 |
| Current liabilities |
9,063
|
7,131
|
4,016 |
| Equity capital |
11,787
|
1,147
|
6,382 |
| - share capital |
3,196
|
942
|
942 |
| Employees (average) |
5
|
5
|
7 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
47.8%
|
9.7%
|
43.3% |
| Turnover per employee |
36
|
150
|
6 |
| Profit as a percentage of turnover |
-8413.8%
|
-1362.5%
|
-21985.4% |
| Return on assets (ROA) |
-58.3%
|
-82.5%
|
-58.5% |
| Current ratio |
39.1%
|
25.8%
|
78.6% |
| Return on equity (ROE) |
-129.2%
|
-889.7%
|
-141.2% |
| Change turnover |
-568
|
708
|
18 |
| Change turnover % |
-76%
|
1727%
|
78% |
| Chg. No. of employees |
0
|
-2
|
2 |
| Chg. No. of employees % |
0%
|
-29%
|
40% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.